Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$453M |
| 2 |
UiPath
PATH
|
+$149M |
| 3 |
Roku
ROKU
|
+$135M |
| 4 |
Zoom
ZM
|
+$125M |
| 5 |
Ginkgo Bioworks
DNA
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGFY
Signify Health, Inc.
SGFY
|
+$456M |
| 2 |
Spotify
SPOT
|
+$133M |
| 3 |
Stratasys
SSYS
|
+$118M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$108M |
| 5 |
Coinbase
COIN
|
+$86.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.64% |
| 2 | Technology | 30.32% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Communication Services | 8.55% |
| 5 | Financials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Compugen
CGEN
$248M
| $760K | 0.01% |
1,157,484
-9,624,137
| -89% | -$13.6M |
|
|
177
CALL
Zoom
ZM
$31.5B
| $692K | ﹤0.01% |
9,400
+200
| +2% | +$19K |
|
|
VIVS
178
VivoSim Labs
VIVS
$3.83M
| $563K | ﹤0.01% |
22,906
-1,397
| -6% | -$44.6K |
|
179
CALL
Tesla
TSLA
$1.43T
| $398K | ﹤0.01% |
1,500
+300
| +25% | +$83.8K |
|
180
PUT
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $396K | ﹤0.01% |
11,000
-28,800
| -72% | -$1.09M |
|
181
ARK Innovation ETF
ARKK
$6.72B
| $358K | ﹤0.01% |
9,493
-48,864
| -84% | -$2.18M |
|
|
182
CALL
ARK Innovation ETF
ARKK
$6.72B
| $317K | ﹤0.01% |
8,400
| – | – |
|
183
ATI
ATI
$28.2B
| $263K | ﹤0.01% |
9,877
+566
| +6% | +$15.8K |
|
184
Carpenter Technology
CRS
$24.4B
| $253K | ﹤0.01% |
8,124
+1,473
| +22% | +$48.7K |
|
185
Hexcel
HXL
$7.1B
| $217K | ﹤0.01% |
4,187
-839
| -17% | -$48.8K |
|
186
DuPont de Nemours
DD
$18.7B
| $210K | ﹤0.01% |
3,325
+43
| +1% | +$3.07K |
|
187
Kodak
KODK
$963M
| $210K | ﹤0.01% |
45,731
+184
| +0.4% | +$1K |
|
188
Xerox
XRX
$381M
| $210K | ﹤0.01% |
16,080
+1,571
| +11% | +$25.4K |
|
189
3M
MMM
$92.3B
| $196K | ﹤0.01% |
2,125
-137
| -6% | -$15K |
|
190
Eastman Chemical
EMN
$8.47B
| $177K | ﹤0.01% |
2,498
-168
| -6% | -$15.1K |
|
|
191
CALL
Coinbase
COIN
$49.2B
| $161K | ﹤0.01% |
2,500
+300
| +14% | +$20.9K |
|
192
CALL
DraftKings
DKNG
$13B
| $150K | ﹤0.01% |
9,900
| – | – |
|
|
PYR
193
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
| $150K | ﹤0.01% |
136,698
-8,400
| -6% | -$12.6K |
|
|
XYZ
194
CALL
Block Inc
XYZ
$49.4B
| $148K | ﹤0.01% |
2,700
| – | – |
|
|
SLGCW
195
CALL
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $132K | ﹤0.01% |
+300,000
| New | +$200K |
|
|
196
CALL
CRISPR Therapeutics
CRSP
$5.75B
| $85K | ﹤0.01% |
1,300
| – | – |
|
197
CALL
ARK Genomic Revolution ETF
ARKG
$1.94B
| $72K | ﹤0.01% |
2,200
| – | – |
|
|
198
CALL
Roku
ROKU
$23.4B
| $68K | ﹤0.01% |
1,200
| – | – |
|
|
199
ARK Genomic Revolution ETF
ARKG
$1.94B
| $52K | ﹤0.01% |
1,581
-9,126
| -85% | -$335K |
|
200
CALL
Pacific Biosciences
PACB
$420M
| $42K | ﹤0.01% |
7,200
| – | – |
|
Similar funds
Cathie Wood's Q3 2022 Portfolio in Review
As of Q3 2022, Cathie Wood held 361 positions worth $14.3B, down 15% from $16.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Cathie Wood's Q3 2022 filing shows 10 new, 102 increased, 126 reduced and 111 closed positions. Its largest new stake was SomaLogic, Inc. Class A Common Stock: 11,017,672 shares worth $32M. The largest sale was Signify Health, Inc., an estimated $456M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cathie Wood's largest Q3 2022 buy was SomaLogic, Inc. Class A Common Stock: 11,017,672 shares worth $32M.
- Cathie Wood added most to Shopify in Q3 2022, an estimated $453M increase.
- Cathie Wood's biggest Q3 2022 reduction was Signify Health, Inc., cutting an estimated $456M.
- Cathie Wood fully exited 1Life Healthcare in Q3 2022, selling an estimated $49.1M.
- Cathie Wood's ten largest holdings make up 44% of its $14.3B portfolio in Q3 2022.
- Cathie Wood opened 10 new positions and closed 111 in Q3 2022.
- Cathie Wood's portfolio value fell 15% quarter-over-quarter to $14.3B.
Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.